1-Attachment C Standard Drug Panel.pdf
PDF 144 KB Posted
- Attached to
- Drug Monitoring
- Solicitation number
- RFP 515-26-0002
- Issued by
- Texas
About this file
This attachment to RFP 515-26-0002 establishes the standard drug panel that laboratories must test for specimens collected under the Texas State Board of Pharmacy's drug screening contract. The panel includes comprehensive testing across multiple drug categories: amphetamines, barbiturates, benzodiazepines, cocaine metabolites, ethyl alcohol, opiates, phencyclidine, cannabinoids, MDMA and ecstasy analogues, fentanyl, and various other controlled substances and pharmaceuticals. Each drug listed includes specified initial cut-off levels and confirmation cut-off levels measured in nanograms per milliliter (ng/mL) or milligrams per deciliter (mg/dL), with most drugs requiring confirmation testing at lower thresholds than initial screening levels. The panel also specifies acceptable ranges for specimen validity testing, including creatinine levels above 20.00 mg/dL, pH between 4.50 and 8.99, and nitrite at 200 micrograms per milliliter.
The standard drug panel serves TSBP licensees who are subject to Disciplinary Orders requiring random drug and alcohol screening. Laboratories responding to this RFP must agree to test all specimens against this complete panel unless otherwise noted or specifically requested by TSBP. The testing protocols outlined in this attachment establish the baseline analytical standards and sensitivity requirements that selected contractors must maintain throughout the contract term.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 3-Attachment A Terms and Conditions.docx | DOCX document | |
| 4-RFP 515-26-0002 Drug Monitoring .doc | DOC document | |
| 2-Attachment B HUB Subcontracting.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
RFP 515-26-0002 Drug Screening
ATTACHMENT C
Standard Drug Panel
Unless otherwise noted or requested by TSBP, the laboratory agrees to test the panel of drugs listed below as TSBP’s standard drug panel for each specimen collected.
DRUG Initial Cut-off Level Confirmation Cut-off Level
Amphetamines
Amphetamine 500 ng/mL 250 ng/mL
Methamphetamine 500 ng/mL 250 ng/mL
Barbiturates
Amobarbital 200 ng/mL 200 ng/mL
Butalbital 200 ng/mL 200 ng/mL
Pentobarbital 200 ng/mL 200 ng/mL
Phenobarbital 200 ng/mL 200 ng/mL
Secobarbital 200 ng/mL 200 ng/mL
Benzodiazepines
Lorazepam 200 ng/mL 200 ng/mL
Oxazepam 200 ng/mL 200 ng/mL
Nordiazepam 200 ng/mL 200 ng/mL
Temazepam 200 ng/mL 200 ng/mL
Clonazepam 200 ng/mL 200 ng/mL
Flunitrazepam 200 ng/mL 200 ng/mL
Triazolam 200 ng/mL 200 ng/mL
Flurazepam 200 ng/mL 200 ng/mL
Alprazolam 200 ng/mL 200 ng/mL
Midazolam 200 ng/mL 200 ng/mL
Cocaine Metabolites 150 ng/mL 100 ng/mL
Ethyl Alcohol 20 mg/dL 20 mg/dL
Ethylglucuronide (EtG) 500 ng/mL 500 ng/mL
Ethylsulfate (EtS) 100 ng/mL 100 ng/mL
Zolpidem 100 ng/mL 100 ng/mL
Methadone and EDDP 300 ng/mL 300 ng/mL
Norbuprenorphine 5 ng/mL 5 ng/mL
Buprenorphine 5 ng/mL 5 ng/mL
Opiates
Morphine 300 ng/mL 300 ng/mL
Oxymorphone 300 ng/mL 300 ng/mL
Hydromorphone 300 ng/mL 300 ng/mL
Codeine 300 ng/mL 300 ng/mL
Oxycodone 300 ng/mL 300 ng/mL
Hydrocodone 300 ng/mL 300 ng/mL
6-Acetylmorphine 300 ng/mL 10 ng/mL
Phencyclidine 25 ng/mL 25 ng/mL
Propoxyphene 300 ng/mL 200 ng/mL
RFP 515-26-0002 Drug Screening
Norpropoxyphene 300 ng/mL 200 ng/mL
Cannabinoids 20 ng/mL 10 ng/mL
MDMA
Ecstasy Analogues (MDMA, MDEA, MDA) 250 ng/mL 250 ng/mL
Fentanyl 1 ng/mL 1 ng/mL
Meperidine 100 ng/mL 100 ng/mL
Tramadol 100 ng/mL 100 ng/mL
Meprobamate 200 ng/mL 200 ng/mL
Naloxone 100 ng/mL 100 ng/mL
Naltrexone 100 ng/mL 100 ng/mL
Nalbuphine 100 ng/mL 100 ng/mL
Ketamine 100 ng/mL 100 ng/mL
Pentazocine 100 ng/mL 100 ng/mL
Butorphanol 100 ng/mL 100 ng/mL
Methylphenidate 500 ng/mL 500 ng/mL
Phenmetrazine 500 ng/mL 500 /mL
Creatinine >20.00 mg/dL = acceptable range pH 4.50 – 8.99 = acceptable range
Nitrite 200 mcg/mL 200 mcg/mL
File details come from the government source that posted it. Updated .